Importantly, HMGB1 binds specifically to the major cisplatin-DNA adducts, 1,2-intrastrand d(GpG) and d(ApG) cross-links, which comprise 90% of the lesions, inhibiting repair of DNA damage by the NER and sensitizing cancer cells to cisplatin [108]. Here, HMGB1 is linked to cancer.